ATRAPRO DERMAL SPRAY Rx
Generic Name and Formulations:
Electrolyzed water, sodium chloride, and preservatives: sodium hypochlorite (0.004%), hypochlorous acid (0.003%); topical soln.
Indications for ATRAPRO DERMAL SPRAY :
Management via debridement of wounds such as stage I-IV pressure ulcers, partial and full thickness wounds, diabetic foot ulcers, post surgical wounds, first- and second degree burns, grafted and donor sites.
Apply to affected area 3 times daily (or as needed).
Avoid contact with eyes. Discontinue if sensitivity or chemical irritation occurs.
Local reactions (eg, burning, stinging).
Clinical Pain Advisor Articles
- Virtual Reality May Effectively Reduce Sensory, Affective, and Cognitive Pain During Labor
- Suprazygomatic Sphenopalatine Ganglion Block May Quickly Relieve Status Migrainosus Pain
- Reducing Mortality After Overdose: Is Treatment for Opioid Use Disorder Effective?
- Low Literacy Self-Management Program for Chronic Pain May Be Effective
- A Physician's Guide to Incorporating Patient Spirituality in Practice
- Neuropathic Pain Medications
- Higher Buprenorphine Dose May Not Increase Severity of Neonatal Abstinence Syndrome
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Ketamine Infusions May Be Effective for Refractory Headache
- Physical, Psychosocial Activity May Be Protective Against Development of Chronic Pain in Older Adults
- The Challenge of Compassion in Modern Healthcare Settings
- Republican Opposition to Obamacare: What's Done, What's to Come
- Lowering Default Pill Counts in EMRs May Effectively Reduce Postoperative Opioid Prescription Numbers
- Steps Taken to Increase Use of Electronic Tools in Medicine
- Daily and Retrospective Pain Measurements Comparable in Hip Osteoarthritis